CovenantTerminal
Methodology
Biological Products, (No Diagnostic Substances)
3 active credit facilities from SEC filings.
4D Molecular Therapeutics, Inc.
Loan and Security Agreement
$200m
n/a
Not yet measured
Coherus Oncology, Inc.
LOAN AND SECURITY AGREEMENT
$100m
n/a
Not yet measured
ELUTIA INC.
LOAN AND SECURITY AGREEMENT
n/a
n/a
Not yet measured